Patents by Inventor David John Mangelsdorf

David John Mangelsdorf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6893830
    Abstract: The present invention provides a method of screening for agonists of an oxycholesterol activator of LXR? transcription, comprising the steps of: introducing a reporter construct and an LXR expression construct into a host cell; treating the host cell with potential LXR-specific ligands; and identifying compounds which activate LXR? transcription. Also provided is a method of screening for antagonists of an oxycholesterol activator of LXR? transcription, comprising the steps of: introducing a reporter construct and an LXR expression construct into a host cell; pretreating the host cell with activators of LXR? transcription; contacting the host cell with potential antagonists of LXR? transcription; and identifying compounds which block the activation the LXR? transcription.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: May 17, 2005
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Bethany A. Janowski, David John Mangelsdorf
  • Patent number: 5707800
    Abstract: DNA segments have been discovered, and characterized by sequence, which are response elements operative to confer responsiveness to retinoic acid, or derivatives thereof, for the transcriptional activation of promoters in cells. By using transcriptional control regions comprising response elements of the present invention in combination with a functional promoter, it is now possible to provide recombinant DNA vectors containing a gene, the transcription (and, thereby, also expression) of which is under the control of a promoter, the transcriptional activity of which is responsive to (and increased by) retinoic acid or derivatives thereof.
    Type: Grant
    Filed: November 28, 1994
    Date of Patent: January 13, 1998
    Assignee: The Salk Institute for Biological Studies
    Inventors: David John Mangelsdorf, Ronald M. Evans, Kazuhiko Umesono, Steven A. Kliewer